[MP-202406 ] Tovorafenib (Glioma)
Last updated 16.09.2025
Project no.:
MP-202406
Report type:
Status:
Commission work started
Department/Division:
Drug Assessment
Topic:
Cancer
Indication:
Treatment of paediatric low-grade glioma (LGG)
Note:
This Joint Clinical Assessment (JCA) is being conducted in cooperation with the NCPE (National Centre for Pharmacoeconomics) Ireland.
Further background information can be found here: European health technology assessment
| Stage | Date |
|---|---|
| 1st quarter, 2025 | |
| 2nd quarter, 2026 |